Ophthalmology
-
Randomized Controlled Trial Comparative Study
Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.
To determine the clinical efficacy and safety of moxifloxacin (1.0%) in patients with bacterial keratitis compared with patients treated with ofloxacin (0.3%) or fortified tobramycin (1.33%)/cephazolin (5%). ⋯ No difference in healing rate, cure rate, or complications between fortified cephazolin and tobramycin, ofloxacin, or moxifloxacin was seen in this study.